Comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 vs Abdominal Cystic Lymphangioma C2930929
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Impaired Androgen Production and Abdominal Cystic Lymphangioma for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
A disorder where androgen production is impaired in 46,XY individuals. Results in undervirilization and atypical genital development. Treated with hormone replacement and supportive care.
Abdominal Cystic Lymphangioma C2930929
A non-cancerous fluid-filled growth developing from lymphatic vessels in the abdomen. Usually found in children. Treatment may involve surgical removal or other interventions.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
0-0
Abdominal Cystic Lymphangioma C2930929
0-null
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
severe
Abdominal Cystic Lymphangioma C2930929
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
Chronic
Abdominal Cystic Lymphangioma C2930929
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
No
Abdominal Cystic Lymphangioma C2930929
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
reproductive
Abdominal Cystic Lymphangioma C2930929
congenital
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
endocrine
Abdominal Cystic Lymphangioma C2930929
rare-disease
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-impaired-androgen-production-C5679870 and abdominal-cystic-lymphangioma-C2930929 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | Abdominal Cystic Lymphangioma C2930929 | Discriminating power |
|---|---|---|---|
| Genital appearance | Undervirilization or atypical genital development may be present in a 46,XY person. | Genital development is not a defining feature. | High |
| Abdominal mass or swelling | Not an expected primary finding from the supplied description. | A fluid-filled abdominal lymphatic growth may cause a mass or swelling, often in children. | High |
| Hormonal features | Impaired androgen production is central, but exact hormone patterns are not established here. | No endocrine mechanism is described. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 when
Atypical genital development in a 46,XY individual
The source links this condition to impaired androgen production and undervirilization.
High
Need for endocrine and supportive care planning
Hormone replacement and supportive care are described, without specifying doses.
Moderate
Chronic reproductive or endocrine concern
The supplied axes classify it as chronic, severe, and endocrine.
Moderate
Choose Abdominal Cystic Lymphangioma C2930929 when
Suspected fluid-filled abdominal lymphatic growth
The source describes a non-cancerous cystic lesion arising from abdominal lymphatic vessels.
High
Childhood abdominal mass evaluation
It is usually found in children, although age alone is not diagnostic.
Moderate
Consideration of removal or other intervention
Treatment may involve surgery or other interventions after specialist assessment.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | Abdominal Cystic Lymphangioma C2930929 | Interpretation |
|---|---|---|---|
| Karyotype | A 46,XY karyotype is part of the concept name, but testing must be confirmed clinically. | No characteristic karyotype is supplied. | Karyotype supports classification only with clinical and endocrine findings. |
| Androgen-related endocrine testing | May be used to assess impaired androgen production; no cutoff is established here. | Not indicated by the supplied description. | Abnormal results are not themselves a complete diagnosis. |
| Abdominal imaging | No characteristic abdominal imaging finding is supplied. | Imaging may suggest a cystic abdominal lymphatic lesion, pending confirmation. | Imaging appearance requires clinician and pathology correlation. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
- Outcome
- A chronic endocrine condition whose individual outcome is not quantified here.
- Factors
- Androgen impairment, genital development, and response to supportive care may matter.
Abdominal Cystic Lymphangioma C2930929
- Outcome
- A non-cancerous lesion whose course after observation or intervention is not quantified.
- Factors
- Size, location, symptoms, and treatment choice may influence course.
Time frame: Both are labeled chronic, but no specific timeline is established.
Prognosis should be individualized; the source does not establish comparative survival.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization-related effects | Atypical genital development and related care needs may occur. Not described. Specific complications and outcomes are not established in the source. |
| Mass-related abdominal effects | Not a primary feature in the supplied data. A cystic growth may cause local effects, but exact symptoms are not listed. Do not assume pain, obstruction, or rupture without clinical evidence. |
| Treatment-related burden | Hormone replacement and supportive care may be ongoing. Surgery or other intervention may be considered. Risks, doses, and recurrence rates are not provided. |
Patient education highlights
- HighDifferent conditions
These conditions affect different systems and are not interchangeable diagnoses.
- HighSpecialist confirmation
Endocrine, genetics, or surgical specialists should interpret tests and guide care.
- MediumAvoid unsupported numbers
Prevalence, laboratory cutoffs, mortality, and medication doses are not established here.